Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects
出版年份 2017 全文链接
标题
Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 18, Issue 16, Pages 1679-1689
出版商
Informa UK Limited
发表日期
2017-10-25
DOI
10.1080/14656566.2017.1391217
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells
- (2018) Marije J. Veenstra et al. Oncotarget
- Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids
- (2017) Ivana Sullivan et al. EUROPEAN JOURNAL OF CANCER
- High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study
- (2017) Andrea Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin Receptor Antagonists for Imaging and Therapy
- (2017) Melpomeni Fani et al. JOURNAL OF NUCLEAR MEDICINE
- Biodistribution, Pharmacokinetics, and Dosimetry of 177 Lu-, 90 Y-, and 111 In-Labeled Somatostatin Receptor Antagonist OPS201 in Comparison to the Agonist 177 Lu-DOTATATE: The Mass Effect
- (2017) Guillaume P. Nicolas et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antisecretory Effects of Chimeric Somatostatin/Dopamine Receptor Ligands on Gastroenteropancreatic Neuroendocrine Tumors
- (2017) Anne Couvelard et al. PANCREAS
- Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
- (2017) James Yao et al. OncoTargets and Therapy
- Everolimus treatment for neuroendocrine tumors: latest results and clinical potential
- (2017) Sara Pusceddu et al. Therapeutic Advances in Medical Oncology
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Neuroendocrine Tumors
- (2017) Journal of the National Comprehensive Cancer Network
- Peptide receptor radionuclide therapy of neuroendocrine tumours
- (2016) Tessa Brabander et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study
- (2016) Martyn E Caplin et al. ENDOCRINE-RELATED CANCER
- Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1–Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression
- (2016) Gerard V. Walls et al. ENDOCRINOLOGY
- Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors
- (2016) Omid Fotouhi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Upregulation of Key Molecules for Targeted Imaging and Therapy
- (2016) V. F. Taelman et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions
- (2016) C. M. Deroose et al. JOURNAL OF NUCLEAR MEDICINE
- Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells
- (2016) Roxanne C.S. van Adrichem et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
- (2016) M. Pavel et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
- (2016) B. Niederle et al. NEUROENDOCRINOLOGY
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
- (2016) Anja Rinke et al. NEUROENDOCRINOLOGY
- Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer
- (2016) Lisa Bodei et al. SEMINARS IN NUCLEAR MEDICINE
- The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
- (2016) Seung Tae Kim et al. Journal of Cancer
- 177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model
- (2016) Seval Beykan et al. EJNMMI Research
- Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
- (2015) M. E. Caplin et al. ANNALS OF ONCOLOGY
- The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis
- (2015) Sebastian Richards-Taylor et al. JOURNAL OF CLINICAL PATHOLOGY
- Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models
- (2015) S. U. Dalm et al. JOURNAL OF NUCLEAR MEDICINE
- Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition
- (2015) Mauro Cives et al. NEUROENDOCRINOLOGY
- Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
- (2015) Edward Wolin et al. Drug Design Development and Therapy
- Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?
- (2015) Kalliopi Domvri et al. Journal of Cancer
- Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours
- (2014) V. Ramundo et al. CLINICAL ENDOCRINOLOGY
- Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures
- (2014) A. Mohamed et al. ENDOCRINE-RELATED CANCER
- Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors
- (2014) Andrea Giustina et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Parathyroid Hormone-Related Peptide (PTHrP) Secretion by Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Clinical Features, Diagnosis, Management, and Follow-Up
- (2014) Kimberly Kamp et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study
- (2014) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study
- (2012) Larry K Kvols et al. ENDOCRINE-RELATED CANCER
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
- (2011) Gherardo Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
- (2011) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
- (2009) Andrea Giustina et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan)
- (2009) N. Hillman et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
- (2009) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines
- (2008) Mark Kidd et al. CANCER
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Cell Growth Inhibition and Functioning of Human Somatostatin Receptor Type 2 Are Modulated by Receptor Heterodimerization
- (2008) Michael Grant et al. MOLECULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now